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The typical Hodgkin and Reed-
Sternberg (HRS) cells are thought to
represent the malignant cellular ele-
ments of Hodgkin’s disease (HD). The
detection of immunoglobulin gene rear-
rangements in HRS cells indicates that
they are clonally derived from B cells
(1–8), but immunogenotyping, as such,
does not provide any information on
specific gene alterations possibly in-
volved in the molecular pathology of
HD. In many tumors, highly informative
polymorphic DNA markers may iden-
tify loci harboring clonal loss of hetero-
zygosity (LOH) and thus help to trace
tumor suppressor genes(9,10). Al-
though in HD, cytogenetic data suggest
that nonrandom chromosomal deletions
may occur at several loci, including
1q42, 4q26, and others, very little (if
anything) is known about clonal LOH in
HRS cells at the molecular level(11–
15). We, therefore, set out to study mi-
crodissected HRS cells from classical
types of HD at candidate loci for LOH
with a highly sensitive microsatellite
polymerase chain reaction (PCR) assay.
In seven patients with classical HD,
HRS cells and surrounding cells includ-
ing bystander lymphocytes were laser
microdissected from formalin-fixed,
paraffin-embedded tissue sections
(Table 1). From a patient with nodular-
sclerosing HD (patient 6), samples were
taken at presentation (6a) and at relapse
(6b). In two patients (patient 6 and pa-
tient 7, a patient with mixed cellularity-
type HD), frozen sections of lymphoma
tissue yielded high-molecular-weight
control DNA from microdissected cell
populations. Buccal smears provided
constitutional high-molecular-weight
DNA in patients 5 and 6(16,17). Pa-
tients gave their informed consent to in-
clude their material in this study. For
molecular analyses, tetranucleotide re-
peat microsatellites were selected
through the Genome Data Base at loci
with a high frequency of chromosomal
deletions in HD, which were predicted
by the cytogenetic literature(11–15),
and located at 1q42 (D1S517), 4q26
(D4S2301), 9p23 (D9S254), and 11q23
(D11S1294). Their PCR primer se-
quences are available in the Genome
Data Base (http://www.gdb.org). A
highly sensitive seminested PCR assay
included a first round that used the prim-
ers indicated above. In a second PCR,
one of the primers in each pair was re-
placed by an internal forward primer
(Fint) or an internal reverse primer
(Rin t ) : 1q42 (D1S517Rint ) 58 -
CATGTGTCCATCAATGGTAG-38;
4q26 (D4S2301Fint) 58-GATGAGT-
GCTTAGACCATAGTA-38 ; 9p23
(D9S254Rint) 58-GTCTCCAATGCAT-
GANCTT-38; and 11q23 (D11S1294Rint)
58-CTGGTTTGCTTTCCCTTTCTT-38
(software4 “Primers! For the WWW”;
http://www.williamstone.com) (Fig. 1,
A). Allelic dropout during amplification
of polymorphic microsatellite fragments
may randomly affect either allele mim-
icking LOH. To exclude this pitfall,
pooled samples of 10 purified HRS cells
from a given patient were amplified
(18,19).Ten picograms of DNA (corre-
sponding to the DNA content of a single
diploid cell) was consistently detected
by our PCR assay. We also used a semi-
nested PCR(1,3,20–22) to examine
HRS cells from patients 3, 4, 6, and 7 for
clonally rearranged immunoglobulin
heavy-chain genes created through join-
ing of variable, diversity, and joining
immunoglobulin gene regions (V-D-J
joining). The primers were a framework
III immunoglobulin gene VH primer 58-
ACACGGC(C/T)(G/C)T(G/A)TAT-
TACTGT-38 and a consensus JH primer
(21) 58-ACCTGAGGAGACGGT-
GACC-38. The seminested primer was
from VLJH sequences (58-GTGAC-
CAGGT(N)CCTTGGCCCCA-38) (22)
(Fig. 1, B).
DNA extracted from buccal smears
and from bystander lymphocytes
showed constitutional individual-
specific microsatellite patterns in all pa-
tients (Fig. 1, A). Of 259 samples of
HRS cells microdissected from forma-
lin-fixed tissue, 59 (23%) yielded a de-
tectable microsatellite PCR product.
Mock picks from tissue sections cleared
of cellular material were consistently
negative by PCR analysis. All patients
except patient 5 reproducibly showed
clonal LOH in HRS cells at one to three
different microsatellite loci (Table 1).
LOH was seen at all loci, but the locus
most frequently altered was D4S2301
(4q26; four of five informative patients).
High-molecular-weight DNA from fresh
HRS cells and corresponding degraded
DNA from formalin-fixed tissue yielded
identical individual-specific microsatel-
lite band patterns (Fig. 1, A). None of
the HRS cell samples showed extra mi-
crosatellite bands(23). Patients 3, 4, 6,
and 7 showed clonal immunoglobulin
heavy-chain gene configurations in HRS
cells and polyclonal patterns in by-
stander lymphoid cells (Fig. 1, B). In
patient 6, a common rearranged immu-
noglobulin heavy-chain gene band in
HRS cells, observed at presentation (6a)
and at relapse (6b), indicated that the
initial monoclonal population of HRS
cells had relapsed. Our immunogeno-
type data from formalin-fixed HRS cells
are in keeping with published data that
HRS cells are mostly monoclonal B-cell
populations(1–8,20,24).
The detection of LOH has several im-
plications in HD. The patients’ buccal
mucosa and bystander lymphocytes
showed constitutional microsatellite pat-
terns indicating that LOH in HRS cells
was an acquired specific genetic feature
of HD. To the best of our knowledge,
this is the first report on microsatel-
lite PCR detection of clonal LOH in
microdissected HRS cells. In contrast
to our approach, classical cytogenetics
permit the study of mitotic cells only
and usually do not permit the identifi-
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Table 1.Pathology of Hodgkin’s disease (HD) samples and results of microsatellite polymerase chain reaction (PCR) analysis in
microdissected Hodgkin and Reed-Sternberg (HRS) cells*
Samples Microsatellite typing
Histologic diagnosis (sample No.) Sex/age, y Stage† CD15/30 EBER LMPb/gp220
D1S517
1q42
D4S2301
4q26
D9S254
9p23
D11S1294
11q22–23
Nodular sclerosing HD (1) M/43 III +/+ + + + ni 1 nd ni
Mixed cellularity HD (2) F/43 III +/+ + + + 2 1 ni 1
Nodular sclerosing HD (3) F/16 III +/+ − nd + 2 1 ni 1
Mixed cellularity HD (4) F/74 III +/+ + + + 1 1 1 2
Nodular sclerosing HD (5) F/38 III −/+ nd nd nd ni nd ni nd
Nodular sclerosing HD (6a) F/69 III −/+ nd nd + 2 nd nd nd
Nodular sclerosing HD in relapse (6b) — −/+ nd − nd 2 2 1 2
Mixed cellularity HD (7) F/71 II +/+ nd − nd 1 ni ni 1
*1 4 patient constitutionally informative and loss of one microsatellite allele (loss of heterozygosity) in HRS cells (data verified twice); 24 patient
constitutionally informative, two alleles retained in HRS cells; +4 immunostaining done and positive; −4 immunostaining done and negative; EBER4
Epstein-Barr virus-encoded RNA; LMP4 Epstein-Barr virus latent membrane protein; M4 male; F4 female; nd4 molecular analysis not done due to lack
of suitable material or failure to obtain PCR amplicons; and ni4 patient not informative.
†Cotswold staging classification.
Fig. 1. A) Microsatellite detection of loss of heterozygosity (LOH) at
D1S517 (1q42) in Hodgkin and Reed-Sternberg (HRS) cells from pa-
tient 7, a patient with a mixed cellularity-type Hodgkin’s disease (HD).
DNA from bystander lymphoid cells and from buccal mucosa shows a
constitutionally heterozygous microsatellite pattern (two allelic bands).
HRS cells isolated from formalin-fixed, paraffin-embedded sections
and fresh-frozen sections show a single lower allele, indicating LOH at
1q42. CD30+ HRS cells as well as bystander lymphocytes and other
infiltrating cells in HD lymphoma sections were microdissected under
an inverted laser microscope (P : A : L : M; GmbH, Wolfratshausen,
Germany)(17) and were subjected to a sensitive seminested microsat-
ellite polymerase chain reaction (PCR). The first PCR round was run on
a Thermal Cycler 480 (Perkin-Elmer, Rotkreuz, Switzerland) with 2
mM MgCl2, all four deoxynucleoside triphosphates (dNTPs, each at 0.1
mM), 1 U of hot-startTaqpolymerase (AmpliTaq Gold; Perkin-Elmer,
Rotkreuz, Switzerland), and 1mM of each primer under the following
conditions: Initial denaturation was at 95 °C for 15 minutes, 30 cycles
of 95 °C for 30 seconds, 55 °C for 30 seconds, and 72 °C for 60 sec-
onds, and the final elongation step was at 72 °C for 7 minutes. One
microliter of a 1 : 20 dilution of first-round PCR amplicons was sub-
jected to a second round of PCR on a Perkin-Elmer 9600 Thermal
Cycler in 1.5 mM MgCl2, all four dNTPs (each at 0.1 mM), 0.5 U of
Boehringer®TaqDNA polymerase, and 1mM of each primer under the
following conditions: Initial denaturation was at 94 °C for 5 minutes, 30
cycles of 94 °C for 30 seconds, 55 °C for 30 seconds, and 72 °C for 60
seconds, and the final elongation step was at 72 °C for 7 minutes. If a
PCR band was identified on agarose gel electrophoresis, 1mL of a
1 : 20 dilution of the respective first-round PCR sample was subjected
to a second round of PCR by use of the appropriate internal32P- abeled primer, as described above. Labeled PCR fragments were subjected to electrophoresis
on denaturing 6% polyacrylamide-sequencing gels and subjected to autoradiography at −70 °C for 2–12 hours as appropriate(19). LOH seen in a given patient
at a particular locus was confirmed by at least one or several repeat analyses of cells separately harvested from adjacent tissue sections.B) Immunoglobulin
heavy-chain gene PCR analysis from patient 6, a patient with nodular sclerosing HD.Lane 1—peripheral blood lymphocytes from a healthy donor;lane
2—Nalm6 (monoclonal B-cell leukemia cell line with rearranged immunoglobulin heavy-chain genes);lane 3—Calu1 (lung cancer cell line with germline
immunoglobulin heavy-chain genes);lane 4—bystander lymphoid cells microdissected from paraffin-embedded HD sections;lanes 5and6—pooled micro-
dissected HRS cells obtained at presentation; andl es 7and8—single HRS cells obtained at relapse. M4 molecular weight marker (100-base-pair [bp] DNA
ladder). HRS cells at presentation and at relapse show a common rearranged immunoglobulin heavy-chain gene band of about 90 bp. Lymphoid cells in lanes
1 and 4 yield multiple rearranged immunoglobulin heavy-chain gene bands indicating polyclonal B-cell populations. The first PCR round was run in 2.5mM
MgCl2, all four dNTPs (each at 0.2 mM), 1 U of hot-startTaq polymerase (AmpliTaq Gold; Perkin-Elmer), and 1.3mM of each immunoglobulin gene primer
under the following conditions: Initial denaturation was at 95 °C for 15 minutes; 10 cycles with a stepwise decrease of annealing temperatures from 65°C to 56 °C
were followed by 30 cycles at 95 °C for 30 seconds, 55 °C for 30 seconds, and 72 °C for 45 seconds and a final elongation step at 72 °C for 7 minutes. The
second-round PCR used 1mL of a 1 : 200 dilution of the first-round PCR product as template and was run under the conditions described above, except for using
2 mM MgCl2 and running 40 cycles with an annealing temperature of 55 °C. The final PCR products were separated on 4%–20% polyacrylamide gradient gels
and visualized by ethidium bromide staining.
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cation of the lineage of cells being
karyotyped. The detection of LOH re-
stricted to HRS cells is consistent with
the view that they are clonally derived
from a common single cell of origin
(16,25–27).The probability in a given
patient that all HRS cells tested would
have lost the same allelic microsatellite
band independently or by chance is .002
(i.e., 0.5n − 1, wheren is the number of
HRS cells examined) and, therefore, is
low (28). Our findings thus confirm and
extend molecular immunogenotype data
on the clonality of HRS cells in classical
HD with a molecular marker system un-
related to the configuration of immuno-
globulin genes.
The detection of LOH in tumor cells
at a particular locus indicates clonality
and by the same token points to a site in
the genome possibly harboring inacti-
vated tumor suppressor genes. In non-
Hodgkin’s lymphomas, inactivation of
tumor suppressor genes has been de-
scribed at the p53 gene or the p16INK4a
locus. Our work now shows that in clas-
sical HD, clonal LOH may be present at
loci, such as 1q42, 4q26, 9p23, 11q22–
23, and possibly others. The dense ge-
nomic map of microsatellite markers
now available will help to narrow down
such loci as a next important step for the
eventual cloning of tumor suppressor
genes operative in the molecular pathol-
ogy of HD.
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